Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Clinically, it has been reported that chronic pain induces depression, anxiety, and reduced quality of life. The endogenous opioid system has been implicated in nociception, anxiety, and stress. The present study was undertaken to investigate whether chronic pain could induce anxiogenic effects and changes in the opioidergic function in the amygdala in mice. We found that either injection of complete Freund's adjuvant (CFA) or neuropathic pain induced by sciatic nerve ligation produced a significant anxiogenic effect at 4 weeks after the injection or surgery. Under these conditions, the selective mu-opioid receptor agonist [D-Ala2,N-MePhe4,Gly5-ol]-enkephalin (DAMGO)- and the selective delta-opioid receptor agonist (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80)-stimulated [35S]GTPgammaS binding in membranes of the amygdala was significantly suppressed by CFA injection or nerve ligation. CFA injection was associated with a significant increase in the kappa-opioid receptor agonist 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride (ICI199,441)-stimulated [35S]GTPgammaS binding in membranes of the amygdala. The intracerebroventricular administration and microinjection of a selective mu-opioid receptor antagonist, a selective delta-opioid receptor antagonist, and the endogenous kappa-opioid receptor ligand dynorphin A caused a significant anxiogenic effect in mice. We a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in the GTPgs binding of k-opioid receptor-specific ligands in the amygdala were associated with anxiety that was produced by Complete Freund's Adjuvantinduced chronic pain or sciatic nerve ligation-induced neuropathic pain (Narita et al., 2006).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Narita et al., 2006
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“A guide cannula (AG-9, Eicom Co., Kyoto, Japan) was implanted into the basolateral amygdala (from bregma: posterior 2.8 mm, lateral + 5.0 mm, ventral 7.9 mm) according to the atlas of Paxinos and Watson (1998).”
InfluentialThe rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
HALEY, T. J., & McCORMICK, W. G. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,526 · cited 2×
“Intracerebroventricular administration was performed as described previously (Haley and McCormick, 1957).”
MethodOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292 · cited 3×
“The distributions of m-, d-, and k-opioid receptor mRNAs overlap in many brain regions including the amygdala (Mansour et al, 1995).”
BackgroundInfluentialCloning of a Delta Opioid Receptor by Functional Expression
Evans, C. J., Keith, D. E., Morrison, H., Magendzo, K., & Edwards, R. H. (1992) · Science · doi:10.1126/science.1335167 · Cited by 1,233 · cited 2×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
BackgroundAnatomy of CNS opioid receptors
Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., & Watson, S. J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90093-8 · Cited by 1,194
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010 · cited 1×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
BackgroundPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857 · cited 2×
“Furthermore, k agonists produce a dysphoria similar to that noted in depression and chronic stress (Pfeiffer et al, 1986).”
BackgroundRegional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2001) · Science · doi:10.1126/science.1060952 · Cited by 841 · cited 2×
“As previously reported in healthy human subjects, sustained pain induces a reduction of m-opioid receptor availability in the amygdala as measured by positron emission tomography (Zubieta et al, 2001).”
MethodMolecular cloning and functional expression of a mu opioid receptor from rat brain
Chen, Y., Mestek, A., Liu, J., Hurley, A., & Yu, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90214-3 · Cited by 810 · cited 1×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
Background
Cited by
Cognitive and emotional control of pain and its disruption in chronic pain
Bushnell, M. C., Čeko, M., & Low, L. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3516 · Cited by 2,076
Animal models of pain: progress and challenges
Mogil, J. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2606 · Cited by 1,120
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
“The presence of activated KOR in the amygdala, hippocampus, dorsal raphe, and nucleus accumbens is consistent with other reports showing KOR-mediated effects in these structures (Wagner et al., 1993; Pliakas et al., 2001; Tao and Auerbach, 2002; Narita et al., 2006, Bruchas et al., 2007).”
ResultDynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
“Chronic pain also increases the functional coupling of KORs to G-proteins in the mouse amygdala, while decreasing MOR and DOR coupling, and these changes are associated with pain-induced anxiety-like states (Narita et al., 2006).”
BackgroundDe Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., Aboud, M., Maione, S., Comai, S., & Gobbi, G. (2019) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 393
“surgery.(60) In thecontext ofmooddisorders, acuteCBD treatment (30”
The delta opioid receptor: an evolving target for the treatment of brain disorders
Pradhan, A. A., Befort, K., Nozaki, C., Gavériaux-Ruff, C., & Kieffer, B. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.008 · Cited by 365
Alcohol dependence as a chronic pain disorder
Egli, M., Koob, G. F., & Edwards, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.010 · Cited by 347
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Increases in the GTPgs binding of k-opioid receptor–specific ligands in the amygdala were associated with anxiety that was produced by Complete Freund’s Adjuvant– induced chronic pain or sciatic nerve ligation–induced neuropathic pain (Narita et al., 2006).”
MethodThe Anterior Cingulate Cortex Is a Critical Hub for Pain-Induced Depression
Barthas, F., Sellmeijer, J., Hugel, S., Waltisperger, E., Barrot, M., & Yalcin, I. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.004 · Cited by 324
The amygdala between sensation and affect: a role in pain
Veinante, P., Yalcin, I., & Barrot, M. (2013) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-1-9 · Cited by 321
“The influence of the opioid system in the amygdala on pain is supported by various data, including the antinociceptive action of morphine in the CeA, the synergy between the CeA and the PAG co-delivery of opioid ligands [47] and the changes in CeA opioid receptor binding in neuropathic mice [117].”
MethodJennings, E. M., Okine, B. N., Roche, M., & Finn, D. P. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.003 · Cited by 318
“Mouse models of neuropathic (SNL) and chronic inflammatory (CFA) pain have been shown to exhibit increased anxiety-like behaviour, an effect accompanied by reduced binding of m- and d-opioid receptor binding in the amygdala, while k-opioid receptor agonist binding in the amygdala was affected only in the CFA model (Na…”
Background30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Schwarzer, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.006 · Cited by 289
“Marked anxiolytic effects of KOP agonists were opposed by the finding of increased KOP-specific binding in the amygdala in chronic paininduced anxiety in mice (Narita et al., 2006).”
BackgroundSellmeijer, J., Mathis, V., Hugel, S., Li, X.-H., Song, Q., Chen, Q.-Y., Barthas, F., Lutz, P.-E., Karatas, M., Luthi, A., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.3195-17.2018 · Cited by 238
“Preclinical studies have shown that the anxiodepressive-like consequences of chronic pain, as in neuropathic pain condition, can be studied in murine models (Narita et al., 2006; Yalcin et al., 2011; Alba-Delgado et al., 2013) and further highlight the imReceived Nov.”
BackgroundKnoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., & Carlezon, W. A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127415 · Cited by 225
Emotional consequences of neuropathic pain: Insight from preclinical studies
Yalcin, I., Barthas, F., & Barrot, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.002 · Cited by 196
Urban, R., Scherrer, G., Goulding, E. H., Tecott, L. H., & Basbaum, A. I. (2011) · Pain · doi:10.1016/j.pain.2010.12.003 · Cited by 189
Roles of the hippocampal formation in pain information processing
Liu, M.-G., & Chen, J. (2009) · Neuroscience Bulletin · doi:10.1007/s12264-009-0905-4 · Cited by 173
Tsuda, M., Koga, K., Chen, T., & Zhuo, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14001 · Cited by 173
How to study anxiety and depression in rodent models of chronic pain?
Kremer, M., Becker, L. J., Barrot, M., & Yalcin, I. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14686 · Cited by 166
Wittmann, W., Schunk, E., Rosskothen, I., Gaburro, S., Singewald, N., Herzog, H., & Schwarzer, C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.142 · Cited by 165
“On the other hand, Narita et al (2006) showed in the same study marked anxiolytic effects of KOR agonists.”
Sciatic nerve cuffing in mice: A model of sustained neuropathic pain
Benbouzid, M., Pallage, V., Rajalu, M., Waltisperger, E., Doridot, S., Poisbeau, P., Freund‐Mercier, M. J., & Barrot, M. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.10.002 · Cited by 162
“More recent work on a longer time-course, and using tight nerve ligation in mice or rats, revealed that long-term (but not short term) neuropathic pain induces an anxiety phenotype (Narita et al., 2006; Suzuki et al., 2007).”
BackgroundThe molecular neurobiology of chronic pain–induced depression
Humo, M., Lu, H., & Yalcin, I. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03003-z · Cited by 163
Robinson, M. (2009) · Frontiers in Bioscience · doi:10.2741/3585 · Cited by 158
Gaveriaux-Ruff, C., Nozaki, C., Nadal, X., Hever, X. C., Weibel, R., Matifas, A., Reiss, D., Filliol, D., Nassar, M. A., Wood, J. N., et al. (2011) · Pain · doi:10.1016/j.pain.2010.12.031 · Cited by 161
“In addition to its role in chronic pain, delta receptor represents a therapeutic target for affective disorders [18,32,34,54,56].”
BackgroundDelta opioid receptors in brain function and diseases
Chu Sin Chung, P., & Kieffer, B. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.003 · Cited by 159
“Stereotaxic microinjection of several DOR agonists in the hippocampus (Solati et al., 2010), amygdala (Narita et al., 2006a; Randall-Thompson et al., 2010) and cingulate cortex (Narita et al., 2006b) reduced anxiety, and conversely, NTI administration at these brain sites increased levels of…”
BackgroundFunctional GI disorders: from animal models to drug development
Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M. R., Bueller, J. A., & Naliboff, B. D. (2008) · Gut · doi:10.1136/gut.2006.101675 · Cited by 162
Left and right hemispheric lateralization of the amygdala in pain
Allen, H. N., Bobnar, H. J., & Kolber, B. J. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101891 · Cited by 159
“, 2000), and other affective disorders, such as anxiety and depression (Myers and Greenwood-Van Meerveld, 2010; Narita et al., 2006; Tran and Greenwood-Van Meerveld, 2012).”
BackgroundThe dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 180
Hasnie, F. S., Breuer, J., Parker, S., Wallace, V., Blackbeard, J., Lever, I., Kinchington, P. R., Dickenson, A. H., Pheby, T., & Rice, A. S. C. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.029 · Cited by 144
Matsuzawa-Yanagida, K., Narita, M., Nakajima, M., Kuzumaki, N., Niikura, K., Nozaki, H., Takagi, T., Tamai, E., Hareyama, N., Terada, M., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301590 · Cited by 161
“Neuropsychopharmacology that chronic pain-induced emotional dysfunction may be associated with changes in opioidergic function in the amygdala (Narita et al, 2006).”
BackgroundSelf-citationThe impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats
Leite-Almeida, H., Almeida-Torres, L., Mesquita, A. R., Pertovaara, A., Sousa, N., Cerqueira, J. J., & Almeida, A. (2009) · Pain · doi:10.1016/j.pain.2009.02.024 · Cited by 143
“Despite this, there are only a handful of animal studies using models of prolonged pain to assess the impact of chronic pain on emotional behaviour [35,37,53,66,67,92] and none has analysed the”
BackgroundResultIncreased anxiety-like behaviors in rats experiencing chronic inflammatory pain
Parent, A. J., Beaudet, N., Beaudry, H., Bergeron, J., Bérubé, P., Drolet, G., Sarret, P., & Gendron, L. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.001 · Cited by 164
Knoll, A. T., Muschamp, J. W., Daws, S. E., Ferguson, D., Dietz, D. M., Meloni, E. G., Carroll, F. I., Nestler, E. J., Konradi, C., & Carlezon, W. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.017 · Cited by 139
“Our observation that KOR antagonism in the BLA decreases anxiety in the EPM is consistent with evidence that KOR signaling in the BLA mediates the anxiogenic effects of corticotropin releasing factor (CRF) and stress (19, 59).”
BackgroundSex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
Chartoff, E. H., & Mavrikaki, M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00466 · Cited by 135
“To date, the little information available on sex differences in KOR systems comes primarily from studies on KOR-mediated antinociception (Rasakham and Liu-Chen, 2011).”
BackgroundPain mechanisms and their implication for the management of pain in farm and companion animals
Viñuela-Fernández, I., Jones, E., Welsh, E. M., & Fleetwood-Walker, S. M. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.02.002 · Cited by 207
Hammack, S. E., & May, V. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.003 · Cited by 142
“There is an extensive literature describing high rates of comorbidity between pain states and PTSD or related anxiety/ mood disorders (63–66), which may reflect maladaptations in CeA responding (67).”
BackgroundPain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.
Amtmann, D., Askew, R. L., Kim, J., Chung, H., Ehde, D. M., Bombardier, C. H., Kraft, G. H., Jones, S. M., & Johnson, K. L. (2015) · Rehabilitation Psychology · doi:10.1037/rep0000027 · Cited by 129
“Although numerous studies have found that anxiety can affect pain sensitivity (Rhudy & Meagher, 2000), research from animal studies suggests that pain also increases anxiety (Narita et al., 2006; Roeska, Doods, Arndt, Treede, & Ceci, 2008).”
BackgroundNociceptive behavior in animal models for peripheral neuropathy: Spinal and supraspinal mechanisms
Saadé, N. E., & Jabbur, S. J. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.06.002 · Cited by 147
Roeska, K., Doods, H. N., Arndt, K., Treede, R., & Ceci, A. (2008) · Pain · doi:10.1016/j.pain.2008.05.003 · Cited by 141
“Anxiogenic effects were also described after injection of complete Freund’s adjuvant and after partial sciatic nerve lesion [20] as well as in rats with diabetic polyneuropathy [24].”
BackgroundMethodInfluentialThe endocannabinoid system and neuropathic pain
Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2015) · Pain · doi:10.1097/j.pain.0000000000000428 · Cited by 146
“neuropathic pain, including cingulate cortex, amygdala, hippocampus, prefrontal cortex, or nucleus accumbens.(16,76,79) Immune mechanisms are also highly intertwined during neuropathic pain.”
BackgroundPedersen, L. H., Scheel-Krüger, J., & Blackburn-Munro, G. (2007) · Pain · doi:10.1016/j.pain.2006.06.036 · Cited by 121
“Conversely, chronic stress and affective disorders appear to be inextricably linked together and might contribute to signs and symptoms of chronic pain conditions in both animals and humans (Blackburn-Munro and Blackburn-Munro, 2001; Narita et al., 2006).”
BackgroundStress-induced modulation of pain: Role of the endogenous opioid system
Ferdousi, M. I., & Finn, D. P. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.002 · Cited by 131
Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches
Gavériaux‐Ruff, C., & Kieffer, B. L. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834a1f2c · Cited by 136
“Delta receptor activity, as measured by agonist-induced G protein activation, was also altered in the cingulate, cortex, and amygdala under conditions of inflammatory and neuropathic pain (Narita et al., 2006a, 2006b).”
Tejeda, H. A., & Bonci, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.023 · Cited by 123
Martin, T. J., Kim, S. A., Buechler, N. L., Porreca, F., & Eisenach, J. C. (2007) · Anesthesiology · doi:10.1097/00000542-200702000-00020 · Cited by 109
Colasanti, A., Rabiner, E., Lingford-Hughes, A., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367726 · Cited by 107
“Also, the injection of OR antagonist into the BLA decreases time in the lit compartment of a LD transition test in a model of anxiety (Narita et al., 2006).”
BackgroundEffect of environment on the long-term consequences of chronic pain
Bushnell, M. C., Case, L. K., Čeko, M., Cotton, V. A., Gracely, J. L., Low, L. A., Pitcher, M. H., & Villemure, C. (2015) · Pain · doi:10.1097/01.j.pain.0000460347.77341.bd · Cited by 116
“In addition, administration of an analgesic drug can increase the amount of time spent in exposed areas, ie, showing a decrease in anxiety-like behavior.(95,109,156)”
BackgroundDoes the kappa opioid receptor system contribute to pain aversion?
Cahill, C. M., Taylor, A. M. W., Cook, C., Ong, E., Morón, J. A., & Evans, C. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00253 · Cited by 105
“Increased GTPgS binding of KOR-specific ligands in the amygdala of chronic pain animals has also been described (Narita et al., 2006b).”
BackgroundDimitrov, E. L., Tsuda, M. C., Cameron, H. A., & Usdin, T. B. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0312-14.2014 · Cited by 104
“…following injury is thought to contribute to chronic pain and the deleterious effects of pain on mood and cognitive function in animal models (Narita et al., 2006; Kodama et al., 2011; Alba-Delgado et al., 2013; CardosoCruz et al., 2013) and in humans (McWilliams et al., 2003; Ling et al.,…”
BackgroundBravo, L., Micó, J. A., Rey-Brea, R., Perez‐Nievas, B. G., Leza, J. C., & Berrocoso, E. (2012) · Anesthesiology · doi:10.1097/aln.0b013e3182657b3e · Cited by 120
“Similarly, approximately 30 days of neuropathic pain were necessary to induce a depressive and anxiogeniclike profile in rodents.(38,39,42,43) Overall, these findings show Fig.”
BackgroundThe anxiodepressive comorbidity in chronic pain
Yalcin, I., & Barrot, M. (2014) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000116 · Cited by 99
“A possible correlation was also found between the activity of the amygdala mu and delta opioid receptors and neuropathic pain-induced anxiety [67] (Fig.”
BackgroundLiu, M., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.003 · Cited by 115
“amygdala Narita et al. (2006a)”
InfluentialMaciel, I. D. S., Silva, R. B. M., Morrone, F. B., Calixto, J. Β., & Campos, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077227 · Cited by 114
“The CFA dose was selected on the basis of previous publications [17,24] At 1, 2, 3 and 4 weeks following CFA application, the paw edema volume (in ml) was measured by using a plesthysmometer (Ugo Basile).”
MethodEndogenous opioid systems alterations in pain and opioid use disorder
Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 112
Endogenous opiates and behavior: 2006
Bodnar, R. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.002 · Cited by 104
Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety
Munro, G., Erichsen, H. K., & Mirza, N. B. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.002 · Cited by 94
Differential effects of left/right neuropathy on rats’ anxiety and cognitive behavior
Leite‐Almeida, H., Cerqueira, J., Wei, H., Ribeiro-Costa, N., Anjos-Martins, H., Sousa, N., Pertovaara, A., & Almeida, A. (2012) · Pain · doi:10.1016/j.pain.2012.07.007 · Cited by 97
“Other animal studies, using left-sided [33,34,43,71,72,88–91] or right-sided [5,28,41,52,62,63,94] pain diverge, however, in their results concerning pain-related anxiogenic effect.”
Sawada, A., Niiyama, Y., Ataka, K., Nagaishi, K., Yamakage, M., & Fujimiya, M. (2014) · Pain · doi:10.1016/j.pain.2014.05.031 · Cited by 87
“Postoperative analgesia was not given as in previous studies [1,22,43].”
MethodResultBurke, N. N., Llorente, R., Marco, E. M., Tong, K., Finn, D. P., Viveros, M., & Roche, M. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.05.003 · Cited by 90
The Role of Amygdalar Mu-Opioid Receptors in Anxiety-Related Responses in Two Rat Models
Wilson, M. A., & Junor, L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301675 · Cited by 76
Sauriyal, D. S., Jaggi, A. S., & Singh, N. (2011) · Neuropeptides · doi:10.1016/j.npep.2010.12.004 · Cited by 87
“also proposed that chronic pain-induced anxiety is associated with an increased kappa-opioid receptor-specific binding in the amygdala (Tsuda et al., 1996; Narita et al., 2006).”
Li, M.-J., Liu, L., Chen, L., Cai, J., Wan, Y., & Xing, G. (2016) · Pain · doi:10.1097/j.pain.0000000000000827 · Cited by 86
“To determine whether chronic exposure of FS could also produce anxiety-like behavior in rats, we performed EPM test, which has been extensively used as a measurement of anxietylike behavior in animal models.(12,52,68) The results revealed that there were no significant differences in the number of open arms entries (3.”
MethodSheahan, T. D., Siuda, E. R., Bruchas, M. R., Shepherd, A. J., Mohapatra, D. P., Gereau, R. W., & Golden, J. P. (2017) · Neurobiology of Pain · doi:10.1016/j.ynpai.2017.09.001 · Cited by 80
“However, anxiety-like behavior has been detected in rodents using the elevated plus maze after both inflammation and nerve injury, and is reversed by anxiolytics and analgesics (Dimitrov et al., 2014; Liu et al., 2015; Narita et al., 2006; Parent et al., 2012; Refsgaard et al., 2016; Roeska et al., 2009).”
BackgroundInfluentialPedersen, L. H., & Blackburn-Munro, G. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0281-3 · Cited by 82
“that incorporate a number of the key sensory abnormalities observed in human neuropathic pain patients might also be associated with altered mood status (Blackburn-Munro 2004; Narita et al. 2005).”
Background“Bedside-to-Bench” Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes
Cobos, E., & Portillo-Salido, E. (2013) · Current Neuropharmacology · doi:10.2174/1570159x113119990041 · Cited by 74
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Jacobson, M. L., Browne, C. A., & Lucki, I. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023317 · Cited by 77
Central opioidergic neurotransmission in complex regional pain syndrome
Klega, A., Eberle, T., Buchholz, H., Maus, S., Maihöfner, C., Schreckenberger, M., & Birklein, F. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7ca2e · Cited by 74
Rezayof, A., Hosseini, S.-S., & Zarrindast, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.030 · Cited by 75
Hasnie, F. S., Wallace, V. C. J., Hefner, K. R., Holmes, A., & Rice, A. S. C. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem087 · Cited by 82
Pregabalin attenuates place escape/avoidance behavior in a rat model of spinal cord injury
Baastrup, C., Jensen, T. S., & Finnerup, N. B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.008 · Cited by 66
“Anxiety is a frequent comorbidity in different pain conditions including SCI (Haythornthwaite and Benrud-Larson, 2000; Narita et al., 2006; Nicholson and Verma, 2004; Roeska et al., 2008; Wallace et al., 2008),making it an important possible confounder.”
Seno, M. D. D. J., de Assis, D. V., Gouveia, F. V., Antunes, G. F., Kuroki, M. A., de Oliveira, C. C., dos Santos, L. C. T., Pagano, R. L., & Martinez, R. C. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-31962-w · Cited by 78
Sieberg, C. B., Taras, C., Gomaa, A., Nickerson, C. A., Wong, C., Ward, C., Baskozos, G., Bennett, D., Ramirez, J. D., Themistocleous, A. C., et al. (2018) · PAIN Reports · doi:10.1097/pr9.0000000000000651 · Cited by 65
“Again, published data in this area are contradictory, with some showing no association between nerve injury and anxiety behavior,(17,40) whereas others show that neuropathic injury increases anxietylike behavior.(9,23,25,38,45) Interestingly, our findings combined with these other studies suggest a time sensitivity to…”
BackgroundResultMetformin: A Prospective Alternative for the Treatment of Chronic Pain
Baeza‐Flores, G. D. C., Guzmán‐Priego, C. G., Flores, L. I. P., Murbartián, J., Torres‐López, J. E., & Granados‐Soto, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.558474 · Cited by 69
“, 2020) whereas that chronic stress exacerbates chronic pain (Narita et al., 2006; Li et al., 2017; Gruener et al., 2018; Sieberg et al., 2018).”
BackgroundThe role of the dynorphin/κ opioid receptor system in anxiety
Hang, A., Wang, Y.-J., He, L., & Liu, J.-G. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.32 · Cited by 62
Jin, Y., Meng, Q., Mei, L., Zhou, W., Zhu, X., Mao, Y., Xie, W., Zhang, X., Luo, M., Tao, W., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001724 · Cited by 70
Zhong, F., Liu, L., Wei, J., Hu, Z., Li, L., Wang, S., Xu, J., Zhou, X., Li, C.-Q., Yang, Z., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00776 · Cited by 68
“Like the anxiogenic effect of neuropathic pain (43, 44), CFA injection induced persistent inflammatory pain, which developed the anxiety-like behavior 3 weeks after CFA injection.”
BackgroundPitzer, C., Porta, C. L., Treede, R., & Tappe‐Theodor, A. (2018) · European Journal of Pain · doi:10.1002/ejp.1303 · Cited by 67
A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors
Randall-Thompson, J., Pescatore, K. A., & Unterwald, E. M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1980-y · Cited by 61
“…DOR agonists, which have been shown to reduce anxiety-like behaviors in the elevated plus maze and other tests of anxiety (Hirata et al. 2007; Narita et al. 2006b; Perrine et al. 2006; Saitoh et al. 2004), and extends those findings by identifying an anatomical site of action for this…”
Neuropathic Pain Causes Memory Deficits and Dendrite Tree Morphology Changes in Mouse Hippocampus
Tyrtyshnaia, A. A., & Manzhulo, I. (2020) · Journal of Pain Research · doi:10.2147/jpr.s238458 · Cited by 60
“teristic of the limbic system impairment: anxiety, anhedonia, impaired spatial, episodic or contextual memory.(14,17,25,29,30) However, the detailed mechanisms underlying neuropathic pain influence on the limbic system remain poorly understood.”
BackgroundNeuroplasticity of Supraspinal Structures Associated with Pathological Pain
Boadas‐Vaello, P., Homs, J., Reina, F., Carrera, A., & Verdú, E. (2017) · The Anatomical Record · doi:10.1002/ar.23587 · Cited by 66
“…in the amygdala has been established in electrophysiological and biochemical studies in brain slice preparations obtained from animals after the induction of different pain states, suggesting that brain changes persist regardless of continued afferent inputs, at least in part (Neugebauer, 2015).”
BackgroundHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Fitzgibbon, M., Finn, D. P., & Roche, M. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 57
Wang, Y., Rasakham, K., Huang, P., Chudnovskaya, D., Cowan, A., & Liu‐Chen, L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183905 · Cited by 60
“The endogenous KOPR ligand dynorphin A has been found to induce anxiogenic effects in mice (Narita et al., 2006), whereas KOPR antagonists reduce anxiety (Knoll et al.”
BackgroundAnimal Models for the Study of Comorbid Pain and Psychiatric Disorders
Leite‐Almeida, H., Pinto‐Ribeiro, F., & Almeida, A. (2015) · Modern trends in psychiatry · doi:10.1159/000435929 · Cited by 59
Sun, T., Wang, J., Li, X., Li, Y., Feng, D., Shi, W., Zhao, M., Wang, J., & Wu, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.10.020 · Cited by 58
“Anxiety-like behaviors can also be induced by an injection of complete Freund's adjuvant (CFA) into the hindpaws of mice with persistent inflammatory pain [11].”
BackgroundDorsal hippocampal opioidergic system modulates anxiety‐like behaviors in adult male Wistar rats
Solati, J., Zarrindast, M., & Salari, A. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02143.x · Cited by 53
“Intracerebroventricular microinjection of d-opioid receptor antagonist caused a significant anxiogenic effect in mice.(41) In contrast, the d-opioid receptor knockout mice showed anxiogenic-like responses in the elevated plus-maze and the light–dark box.”
BackgroundNeuronal basis for pain-like and anxiety-like behaviors in the central nucleus of the amygdala
Chen, W.-H., Lien, C., & Chen, C. (2021) · Pain · doi:10.1097/j.pain.0000000000002389 · Cited by 56
Venâncio, A. M., Marchioro, M., Estevam, C. D. S., Seabra, M. S. D. M., de Santana, M. T., Onofre, A. S. C., Guimarães, A. G., de Oliveira, M. G. B., Alves, P. B., Pimentel, H. D. C., et al. (2011) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2011005000147 · Cited by 52
“When pain becomes chronic, the sensory dysfunction is accompanied by several brain disorders, such as anxiety, amnesia and depression (Ling et al., 2007; Narita et al., 2006).”
Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice
Almatroudi, A., Husbands, S. M., Bailey, C. P., & Bailey, S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115586937 · Cited by 56
Sang, K., Bao, C., Xin, Y., Hu, S., Gao, X., Wang, Y., Bodner, M., Zhou, Y., & Dong, X. (2018) · Molecular Pain · doi:10.1177/1744806918783931 · Cited by 59
“Others reported different behavioral profiles in the same anxiety tests.(7,10) A number of factors might be attributed to the incongruency.”
Nerve injury causes long-term attentional deficits in rats
Low, L. A., Millecamps, M., Seminowicz, D. A., Naso, L., Thompson, S. J., Stone, L. S., & Bushnell, M. C. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.027 · Cited by 55
Wang, X., Zhong, X., Li, Z., Wang, H., Zhang, J., Li, F., Zhang, J. J., Dai, R., Xin-Fu, Z., Li, C.-Q., et al. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0150-x · Cited by 49
The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential
Burtscher, J., & Schwarzer, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00245 · Cited by 52
“…model Cain et al., 1990 Neuroprotection of DOPr activation Hypoxia/ischemia, glutamate-induced excitotoxic injury and oxidative stress models Mayfield and D’Alecy, 1994; Zhang et al., 2000; Narita et al., 2006; Yang et al., 2009 the latter, causes convulsions (Lee et al., 1989; Hong et al., 1993).”
BackgroundWatanabe, H., Fitting, S., Hussain, M. Z., Kononenko, O., Iatsyshyna, A. P., Yoshitake, T., Kehr, J., Alkass, K., Druid, H., Wadensten, H., et al. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht204 · Cited by 49
“The κ-system is critical for the modulation of negative emotional states and control of pain processing (Narita et al. 2006; Land et al. 2008; Schwarzer 2009; Shippenberg 2009; Knoll and Carlezon 2010) that both may be preferentially presented and processed in the RH and specifically in the right pgACC (Hsieh et al.”
Wang, D., Tian, Z., Guo, Y., Guo, H., Kang, W., Li, S., Den, Y.-T., Li, X., Feng, B., Feng, D., et al. (2015) · Molecular Pain · doi:10.1186/s12990-015-0013-6 · Cited by 52
“The pathophysiological features and duration of CFA-induced pain in model organisms make the study of pain and pain associated behaviors possible [12].”
BackgroundRelaxation: molecular and physiological significance.
Stefano, G. B., Fricchione, G. L., & Esch, T. (2006) · PubMed · Cited by 58
The affective dimension of pain as a risk factor for drug and alcohol addiction
LeBlanc, D. M., McGinn, M. A., Itoga, C. A., & Edwards, S. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.04.005 · Cited by 48
“In a seminal study by Narita and colleagues, male C57BL/6J mice underwent either sciatic nerve ligation (SNL) to produce neuropathic pain, or hindpaw injection of Complete Freund’s Adjuvant to generate a state of chronic inflammatory pain (Narita et al., 2006).”
A Novel Anxiogenic Role for the Delta Opioid Receptor Expressed in GABAergic Forebrain Neurons
Chung, P. C. S., Keyworth, H. L., Martín‐García, E., Charbogne, P., Darcq, E., Bailey, A., Filliol, D., Matifas, A., Scherrer, G., Ouagazzal, A., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.033 · Cited by 50
“The DOR transcript was undetectable in OB, CPu and NAc, partially decreased in FCx, Hipp and Amy and unchanged in SC, PAG, BS, DRN and VTA of Dlx-MOR mice, and was undetectable overall in CMV-DOR mice.”
BackgroundInfluentialBallantyne, J. C. (2018) · Pain · doi:10.1097/j.pain.0000000000001270 · Cited by 44
“This could contribute to the vulnerability of affected individuals to develop comorbid pain, high-dose opioid use, opioid abuse, depression, anxiety, and post-traumatic stress disorder.(6,20,38,42,66,70,71,73,120)”
BackgroundAmorim, D., David-Pereira, A., Pertovaara, A., Almeida, A., & Pinto‐Ribeiro, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.003 · Cited by 49
“Curiously, although many animal models of chronic inflammatory pain are available and extensively used, only a few studies addressed inflammatory pain and mood disorders comorbidity [4] [5] [6] [7].”
Effect of Chronic Pain on Fentanyl Self-Administration in Mice
Wade, C. L., Krumenacher, P., Kitto, K. F., Peterson, C. D., Wilcox, G. L., & Fairbanks, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079239 · Cited by 43
“More recently, progress has been made in understanding molecular changes that take place in supraspinal regions with the development of chronic pain, including regions that govern reward such as the nucleus accumbens [11], the ventral tegmental area [12-15], and the amygdala [16].”
Background
Metadata
- Authors
- Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T.
- Affiliations
- Hoshi University (JP)
- University of Toyama (JP)
- Corresponding author
- Narita, Minoru
- Suzuki, Tsutomu
- Venue
- Neuropsychopharmacology
- Published
- 2005-08-10
- Volume
- 31
- Issue
- 4
- Pages
- 739-750
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2019397294
- Cited by
- 289
- References
- 42
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 19 · 2020: 25 · 2019: 17 · 2018: 16 · 2017: 10 · 2016: 11 · 2015: 19 · 2014: 19 · 2013: 12 · 2012: 10
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- chronic pain, anxiety, amygdala, opioid system, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, dynorphin A, neuropathic pain, sciatic nerve ligation, complete Freund's adjuvant, thermal hyperalgesia, GTPgammaS binding, anxiogenic effects
- MeSH terms
- Amygdala, Analgesics, Opioid, Analysis of Variance, Animals, Anxiety, Behavior, Animal, Benzamides, Chronic Disease, Diazepam, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Interactions, Dynorphins, Freund's Adjuvant, Injections, Intraventricular, Male, Mice, Inbred C57BL, Naltrexone, Narcotic Antagonists, Narcotics, Pain, Pain Measurement, Piperazines, Protein Binding, Pyrrolidines, Reaction Time, Sciatica, Somatostatin, Sulfur Isotopes, Time Factors, Tranquilizing Agents, Guanosine 5'-O-(3-Thiotriphosphate), Rats, Sprague-Dawley, Maze Learning, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.